港股公告掘金 | 国泰君安国际获国泰海通溢价约44.2%提私有化

智通财经08-10

重大事项：复星医药(02196)：盐酸多巴酚丁胺注射液获注册批准中国生物制药(01177)：贝莫苏拜单抗联合化疗序贯联合安罗替尼一线治疗鳞状非小细胞肺癌新适应症获批上市首程控股(00697)：投资华泰三峡新能源REIT国泰君安国际(01788)获国泰海通(02611)溢价约44.2%提私有化 8月10日复牌迅策(03317)与天合算力签署战略合作备忘共同探索AI与能源融合下的数据基础设施与能源...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2658606503?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-10 09:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658606503","market":"fut","top_or_hot":-1,"title":"港股公告掘金 | 国泰君安国际获国泰海通溢价约44.2%提私有化","media":"智通财经","content":"<div>\n<p>重大事项：复星医药(02196)：盐酸多巴酚丁胺注射液获注册批准中国生物制药(01177)：贝莫苏拜单抗联合化疗序贯联合安罗替尼一线治疗鳞状非小细胞肺癌新适应症获批上市首程控股(00697)：投资华泰三峡新能源REIT国泰君安国际(01788)获国泰海通(02611)溢价约44.2%提私有化 8月10日复牌迅策(03317)与天合算力签署战略合作备忘 共同探索AI与能源融合下的数据基础设施与能源...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1477775.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 国泰君安国际获国泰海通溢价约44.2%提私有化</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 国泰君安国际获国泰海通溢价约44.2%提私有化\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-10 09:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1477775.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>重大事项：复星医药(02196)：盐酸多巴酚丁胺注射液获注册批准中国生物制药(01177)：贝莫苏拜单抗联合化疗序贯联合安罗替尼一线治疗鳞状非小细胞肺癌新适应症获批上市首程控股(00697)：投资华泰三峡新能源REIT国泰君安国际(01788)获国泰海通(02611)溢价约44.2%提私有化 8月10日复牌迅策(03317)与天合算力签署战略合作备忘 共同探索AI与能源融合下的数据基础设施与能源...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1477775.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1508","symbol_name":"富士康概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1477775.html","article_id":"2658606503","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2658606503","pubTimestamp":1786323628,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"重大事项：复星医药(02196)：盐酸多巴酚丁胺注射液获注册批准中国生物制药(01177)：贝莫苏拜单抗联合化疗序贯联合安罗替尼一线治疗鳞状非小细胞肺癌新适应症获批上市首程控股(00697)：投资华泰三峡新能源REIT国泰君安国际(01788)获国泰海通(02611)溢价约44.2%提私有化 8月10日复牌迅策(03317)与天合算力签署战略合作备忘 共同探索AI与能源融合下的数据基础设施与能源T","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601211":"国泰海通","BK1508":"富士康概念","01788":"国泰君安国际","BK1216":"多样化房地产活动","BK4585":"ETF&股票定投概念","BK1167":"电子制造服务","BK0184":"上海国资改革","00697":"首程控股","02038":"富智康集团","BK0276":"资本市场","BK0183":"MSCI概念","VXUS":"国际股票ETF-Vanguard","BK1504":"苹果概念","BK0188":"融资融券","BK0012":"证金概念","BK1163":"半导体产品","BK1564":"中资券商股","02611":"国泰海通","BK0028":"国家队","BK1155":"信息科技咨询与其它服务","KCAI":"KraneShares China Alpha Index ETF","BK0201":"可转债","BK4588":"碎股","03317":"迅策","BK1147":"投资银行业与经纪业","00600":"爱芯元智"},"translate_title":"Hong Kong Stock Announcement Nuggets | Guotai Junan International received a premium of about 44.2% from Cathay Haitong and offered privatization","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601211":1.5,"02611":1.5,"01788":1.5,"03317":0.9,"00697":0.9,"02038":0.9,"KCAI":1.5,"00600":0.9,"VXUS":1.5},"content_text":"重大事项：复星医药(02196)：盐酸多巴酚丁胺注射液获注册批准中国生物制药(01177)：贝莫苏拜单抗联合化疗序贯联合安罗替尼一线治疗鳞状非小细胞肺癌新适应症获批上市首程控股(00697)：投资华泰三峡新能源REIT国泰君安国际(01788)获国泰海通(02611)溢价约44.2%提私有化 8月10日复牌迅策(03317)与天合算力签署战略合作备忘 共同探索AI与能源融合下的数据基础设施与能源Token工厂模式灵宝黄金(03330)：新疆哈巴河华泰公司勘查工作取得重大进展，保有金金属量(矿产资源量)跃升至53.94吨博泰车联(02889)拟不超过14亿元收购成都明夷电子科技70%已发行股份赤峰黄金(06693)：暂停运营老挝勐康稀土项目浙江世宝(01057)拟定增A股募资不超过13.94亿元经营业绩：爱芯元智(00600)发布中期业绩 收入大增181.8%至4.02亿元 边缘AI及智能汽车业务均增超250%广合科技(01989)发布中期业绩 归母净利润9.56亿元 同比增长94.39%富智康集团(02038)发布中期业绩 股东应占溢利930.6万美元 同比增长50.95%沛嘉医疗-B(09996)上半年收入约为4.15亿元至4.35亿元 同比增长约17.4%至23.1%潼关黄金(00340)发盈喜 预计中期股东应占溢利约5.1亿港元至5.3亿港元 同比增加约49%至55%西部水泥(02233)发盈警 预计上半年股东应占溢利同比减少约45%至50%龙湖集团(00960)前7个月实现总合同销售金额 186.4亿元龙源电力(00916)前7个月累计完成发电量约4497.57万兆瓦时 同比下降2.19%越秀地产(00123)前7个月累计合同销售金额约为556.08亿元","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658606503","isCrawlerRequest":true}